Daphne Zohar
Host, Biotech Hangout
“US INDS are down more than 10% since 2020, while China's phase one trial count nearly doubled over the same period from about 600 to over 1,100.”
“Republican lawmakers John Molinar and Ben Klein are asking the FDA to reject clinical data from China unless a trial site has been recently audited by the agency... having [Klein] co sign suggests this isn't just the usual China hawks anymore.”
Daphne Zohar
One-line summary: Biotech Hangout host. Tracked for US vs China trial-volume / IND offshoring claims.
What they're known for
Brief factual context — fill in.
Why they matter to stock-market
Why this person's claims are tracked here — fill in.
Said
Speaker-attributed claims extracted from diarized sources. Each bullet mirrors one entry in quotes: frontmatter — keep them in sync.
-
On us-biotech-strategic-technology-offshoring:
"US INDS are down more than 10% since 2020, while China's phase one trial count nearly doubled over the same period from about 600 to over 1,100." — 2026-08-28-podcast-biotech-hangout-episode-194-august-28-2026 (2026-08-28)
-
On us-biotech-strategic-technology-offshoring:
"Republican lawmakers John Molinar and Ben Klein are asking the FDA to reject clinical data from China unless a trial site has been recently audited by the agency... having [Klein] co sign suggests this isn't just the usual China hawks anymore." — 2026-08-28-podcast-biotech-hangout-episode-194-august-28-2026 (2026-08-28)
Sources
Related
Cross-links — fill in.